Trials / Active Not Recruiting
Active Not RecruitingNCT04702373
Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT
Training in Exercise Activities and Motion for Growth: A Randomized Clinical Trial
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Carelon Research · Academic / Other
- Sex
- All
- Age
- 35 Days
- Healthy volunteers
- Not accepted
Summary
This is a Phase III randomized controlled trial of a passive ROM exercise program that will be performed in infants with HLHS and other single right ventricle anomalies following the Norwood procedure at PHN and Auxiliary Centers.
Detailed description
Growth is often impaired in infants with congenital heart disease (CHD). Nutritional interventions, drug therapy and surgical palliation have had varying degrees of success in enhancing growth. Passive ROM has improved somatic growth in preterm infants and has been demonstrated in a previous Pediatric Heart Network (PHN) to be safe and feasible in neonate's post-Norwood procedure. Improved growth may also favorably impact neurodevelopment, behavioral state, and time to hospital discharge. This study's objectives are to evaluate growth in infants with hypoplastic left heart syndrome (HLHS) or other single right ventricle (RV) anomalies after the Norwood procedure who are randomized to a passive range of motion (ROM) exercise program vs. standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | passive range of motion exercise therapy | Systematic flexion-extension with gentle compression at the end of the movement is performed 10 times at the wrist, elbow, shoulder, ankle, knee, and hip joints. Ten repetitions of adduction-abduction are performed at the shoulder and hip joints. |
Timeline
- Start date
- 2021-02-23
- Primary completion
- 2024-11-30
- Completion
- 2024-12-30
- First posted
- 2021-01-08
- Last updated
- 2024-07-03
Locations
10 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT04702373. Inclusion in this directory is not an endorsement.